20.01.2016 • News

AkzoNobel Acquires all of EkO Peroxide

AkzoNobel has boosted its position in the North American hydrogen peroxide market with the purchase of all outstanding shares in EkO Peroxide, a joint venture with OCI Peroxygens. Financial details of the transaction were not disclosed. The jv established nine years ago is headquartered at AkzoNobel’s site in Columbus, Mississippi, USA, where it operates a hydrogen peroxide plant with a capacity of 63,500 t/y.

Werner Fuhrmann, AkzoNobel’s executive committee member responsible for specialty chemicals, said the acquisition supports the company’s strategic growth objectives for bleaching chemicals, enabling it to strengthen its integrated platform for the production of hydrogen peroxide and sodium chlorate at the Columbus site. Fuhrmann added that the hydrogen peroxide market in North America has improved significantly in recent years.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.